Follow the Saniona AB stock price and the full insider trade history of the company, a publicly traded company based in Finland. Shares are quoted on the FI market, under the supervision of FIN-FSA. Operating in the Health Care sector, Saniona AB has published 19 public disclosures. Market capitalisation: €1.6bn. The latest transaction was reported on 9 September 2026 (Purchase). Among the most active insiders: John Haurum. The full history is openly available.
19
Insider Decl.
n/a
Thresholds
€451,144
16 ops.
Buy Volume
€701,072
3 ops.
Sell Volume
41Σ signal
Buys €451,144€701,072 Sells
Fundamental score
Ranked 34 of 29,064 companies
94.1
score / 100
Value
91
Quality
97
FCF yld12%
Earn yld18%
EV/EBITDA5.1x
ROE41%
Gross mgn99%
Net mgn66%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Saniona AB es una empresa biofarmacéutica centrada en el desarrollo de tratamientos para trastornos del sistema nervioso central y enfermedades metabólicas. Cotiza en la bolsa XSTO.